Abstract
Introduction The BinaxNOW pneumococcal antigen detection assay is an immuno-chromatographic technique where the cell wall polysaccharide instead of capsular polysaccharide is the target. Although intended for use on urine samples, its role in diagnosis of pneumococcal meningitis has been reported by many others. The current study explores its accuracy when compared with real-time PCR.
Methodology CSF samples from suspected meningitis cases were processed for Gram stain and culture following standard protocols. Antigen was detected by BinaxNOW antigen detection assay for Streptococcus pneumoniae. Previously published primers and protocols were used for real-time PCR targeting autolysin (lytA) gene and was considered as the gold standard test.
Results Among the 74 samples tested, pneumococcal antigen was detected in 21.6% (16/74) and qPCR in 11 (14.9%) samples. Antigen detection assay had higher sensitivity (90.9%) when compared with culture (45.5%) while the positive predictive value was the lowest (62.5% and 100% for culture). It was in substantial agreement with the gold standard test with kappa coefficient of 0.685 and an accuracy of 90.5%.
Conclusions The BinaxNOW pneumococcal antigen detection test can be employed for initial screening of samples or point-of-care test owing to its substantial agreement with real-time PCR.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the Jawaharlal Institute of Postgraduate Medical Education and Research [JIP/RES/INTRA-PHD/PHS1/01/2016-17] for conducting research
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institute Ethics Committee for Human Studies, JIPMER, Puducherry
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data necessary for the manuscript has been attached in the supplementary information file. Additional data can be provided by requesting the corresponding author
